Product Information
PILOCARPINE HCL 1.25% EYE DROP is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $24.7400 per ML under NDC 60219236602. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Apr 28, 2025.
Strength
12.5 mg/mL
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219236602
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217733FDA Approved
4/28/2025
On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for PILOCARPINE HCL 1.25% EYE DROP has been published 42 times since Dec 17, 2025, and over the history we have for it it has risen 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.7400 per ML |
|---|---|
| All-time high | $25.5846 (Aug 12, 2026) |
| All-time low | $22.1620 (Dec 17, 2025) |
| 52-week high | $25.5846 |
| 52-week low | $22.1620 |
| Median price | $24.1035 |
| Average price | $23.9561 |
| Largest weekly change | +3.7% (Apr 22, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pilocarpine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PILOCARPINE HCL 1.25% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for PILOCARPINE HCL 1.25% EYE DROP, manufactured by Amneal Pharmaceuticals NY LLC, is $24.7400 per ML (NDC 60219236602), effective Sep 30, 2026.
How has the price of PILOCARPINE HCL 1.25% EYE DROP changed over time?
Over the history we have for it, the NADAC for PILOCARPINE HCL 1.25% EYE DROP has risen 11.6%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for PILOCARPINE HCL 1.25% EYE DROP?
Since Dec 17, 2025, the NADAC for PILOCARPINE HCL 1.25% EYE DROP has ranged from a low of $22.1620 (Dec 17, 2025) to a high of $25.5846 (Aug 12, 2026), with a median of $24.1035 per ML.
Are there cheaper alternatives to PILOCARPINE HCL 1.25% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VUITY 1.25% EYE DROP, is $23.3947 per ML — about 5% below PILOCARPINE HCL 1.25% EYE DROP.
Who manufactures PILOCARPINE HCL 1.25% EYE DROP?
PILOCARPINE HCL 1.25% EYE DROP (NDC 60219236602) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.